Deep learning for Alzheimer's disease diagnosis: A survey.

Alzheimer's disease diagnosis Convolutional neural networks Deep learning Deep neural networks Generative networks Recurrent neural networks

Journal

Artificial intelligence in medicine
ISSN: 1873-2860
Titre abrégé: Artif Intell Med
Pays: Netherlands
ID NLM: 8915031

Informations de publication

Date de publication:
08 2022
Historique:
received: 25 11 2020
revised: 29 04 2022
accepted: 30 05 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: ppublish

Résumé

Alzheimer's Disease (AD) is an irreversible neurodegenerative disease that results in a progressive decline in cognitive abilities. Since AD starts several years before the onset of the symptoms, its early detection is challenging due to subtle changes in biomarkers mainly detectable in different neuroimaging modalities. Developing computer-aided diagnostic models based on deep learning can provide excellent opportunities for the analysis of different neuroimage modalities along with other non-image biomarkers. In this survey, we perform a comparative analysis of about 100 published papers since 2019 that employ basic deep architectures such as CNN, RNN, and generative models for AD diagnosis. Moreover, about 60 papers that have applied a trending topic or architecture for AD are investigated. Explainable models, normalizing flows, graph-based deep architectures, self-supervised learning, and attention mechanisms are considered. The main challenges in this body of literature have been categorized and explained from data-related, methodology-related, and clinical adoption aspects. We conclude our paper by addressing some future perspectives and providing recommendations to conduct further studies for AD diagnosis.

Identifiants

pubmed: 35809971
pii: S0933-3657(22)00097-5
doi: 10.1016/j.artmed.2022.102332
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102332

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

M Khojaste-Sarakhsi (M)

Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands; Department of Industrial Engineering, Amirkabir University of Technology, Tehran, Iran.

Seyedhamidreza Shahabi Haghighi (SS)

Department of Industrial Engineering, Amirkabir University of Technology, Tehran, Iran. Electronic address: shahabi@aut.ac.ir.

S M T Fatemi Ghomi (SMTF)

Department of Industrial Engineering, Amirkabir University of Technology, Tehran, Iran.

Elena Marchiori (E)

Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH